Our data depict that the mice after MWA increased the proportion of CD8+ T cells in the lymph node; the antigen-presenting capacity of DC cells also increased significantly, suggesting that MWA killed tumor cells to release tumor antigen and then promoted local and systemic antitumor immunity in CT26-bearing mice. This evidence concerns the gene CD8A and neoplasm.